æå·è³ç£
æå·è³ç£
ãªãŒããŒããŒã
ããã·ã¥ããŒã
åžå Žæ°
ã€ã³ãžã±ãŒã¿ãŒ
ããªããã£ã
ååŒæ
äžå€®éæš©åååŒæ
忣åååŒæ
ãããã¯ã
ãããã¯ã
ãã£ã³ããŒã³
ã«ã¬ã³ããŒ
AstraZeneca PLCã®æ ªäŸ¡AZN#51
#51
ï¿¥27,313.46
  AstraZeneca PLC Info
- æäŸ¡ç·é¡
- ï¿¥42.35T
1.28% - äžæ¥ããªã¥ãŒã
- ï¿¥36.87B
ãŠã§ããµã€ã
è³ç£ã¿ã€ã
æ ªåŒ
åŸæ¥å¡
94300
èšç«
Apr 6, 1999
äž»èŠååŒæ
Nasdaq
CIKçªå·
0000901832
ããŒã¯ã³åæ ªåŒããŒã¿
- å¹³åããŒã¯ã³åäŸ¡æ Œ
- ï¿¥20.75K
- äŸ¡æ Œå·®
- +ï¿¥6.55K(-24.00%)
- ããŒã¯ã³åè³ç£æäŸ¡ç·é¡
- ï¿¥22.21M
99.75% - ããŒã¯ã³ååºæ¥é«ïŒ24æéïŒ
- ï¿¥42.91M
1.81%
AZNããUSDãžã®äº€æ
AZN
JPY
äŸ¡æ Œããã©ãŒãã³ã¹
å®
ï¿¥27.31K
ï¿¥27.31K
é«
ï¿¥27.31K
ï¿¥27.31K
èªã¿èŸŒã¿äž...
ãåŸ ã¡ãã ããããã£ãŒãããŒã¿ãèªã¿èŸŒãã§ããŸã
AstraZeneca PLC Community
Â
Â
Â
Â
Â
Â
AstraZeneca PLCã«ã€ããŠ
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
人æ°ã®ãªã¢ã«ã¯ãŒã«ãã¢ã»ãã
AstraZeneca PLC äŸ¡æ Œã®çé ä¿¡ããŒã¿
AstraZeneca PLCã®çŸåšã®åžå ŽäŸ¡æ Œã¯ï¿¥27,313.46ã24æéã®ååŒé«ã¯ï¿¥36.87Bã§ãããã®è³ç£ã®æäŸ¡ç·é¡ã¯ãéå»24æéã§-1.29%å€åããï¿¥42.35Tãšãªã£ãŠããŸãã
ããŒã¯ã³åãããAstraZeneca PLCã¯ï¿¥20,759.16ã§ååŒãããŠãããããŒã¯ã³åãããæäŸ¡ç·é¡ã¯ï¿¥22.21Mã24æéã®ååŒé«ã¯ï¿¥42.91Mã§ãããã®ããŒã¯ã³åãããè³ç£ã¯ãéå»24æéã§-99.75%å€åããŸããã